Insider Stock Trading History of Palling David


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Palling David since year 2005. The trader's CIK number is 1401304. At the time of this reporting, Palling David is the Senior VP, Drug Deve of Amicus Therapeutics Inc . (stock ticker symbol FOLD). See this page for all insider trading activities at Amicus Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Palling David since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2009-06-26 FOLD Amicus Therapeutics Inc Sale 7,498 10.00 74,980
2009-06-29 FOLD Amicus Therapeutics Inc Sale 2,500 10.54 26,347
2009-03-30 FOLD Amicus Therapeutics Inc Sale 2 10.00 20
2009-03-25 FOLD Amicus Therapeutics Inc Sale 531 10.00 5,310
2009-03-23 FOLD Amicus Therapeutics Inc Sale 1,740 10.00 17,400
2009-03-19 FOLD Amicus Therapeutics Inc Sale 229 10.00 2,290
2009-02-03 FOLD Amicus Therapeutics Inc Sale 7,500 10.00 75,000
2009-01-08 FOLD Amicus Therapeutics Inc Option Ex 4,924 .64 3,141
2008-10-30 FOLD Amicus Therapeutics Inc Sale 300 10.00 3,000
2008-10-31 FOLD Amicus Therapeutics Inc Sale 2,200 10.00 22,000
2008-09-29 FOLD Amicus Therapeutics Inc Sale 2,500 15.62 39,062
2008-09-08 FOLD Amicus Therapeutics Inc Sale 3,000 14.83 44,496
2008-08-28 FOLD Amicus Therapeutics Inc Sale 2,500 13.77 34,425
2008-07-28 FOLD Amicus Therapeutics Inc Sale 2,500 15.08 37,692
2008-04-24 FOLD Amicus Therapeutics Inc Option Ex 20,000 .64 12,740
2008-04-01 FOLD Amicus Therapeutics Inc Sale 1,250 11.14 13,931
2008-02-28 FOLD Amicus Therapeutics Inc Sale 2,500 10.50 26,262
2008-02-01 FOLD Amicus Therapeutics Inc Sale 3,000 10.00 30,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Palling David (Senior VP, Drug Deve of Amicus Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.